4-Hydroxytestosterone
From Infogalactic: the planetary knowledge core
![]() |
|
![]() |
|
Names | |
---|---|
IUPAC name
4,17-Dihydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
|
|
Other names
4,17β-Dihydroxy-4-androstene-3-one; (17β)-4,17-dihydroxyandrost-4-en-3-one
|
|
Identifiers | |
2141-17-5 ![]() |
|
ChemSpider | 141138 ![]() |
DrugBank | DB01485 ![]() |
Jmol 3D model | Interactive image |
PubChem | 160615 |
UNII | 912GOZ167T ![]() |
|
|
|
|
Properties | |
C19H28O3 | |
Molar mass | 304.42 g/mol |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
4-Hydroxytestosterone (4-OHT), also known as 4,17β-dihydroxy-4-androstene-3-one, is an anabolic steroid. It was first patented by G.D. Searle & Company in 1955 and is testosterone with a hydroxy group at the four position. 4-OHT has moderate anabolic, mild androgenic, and anti-aromatase properties and is similar to the steroid clostebol.
See also
References
<templatestyles src="Asbox/styles.css"></templatestyles>